ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,061Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 890

$950K Total Retail Price of All Prescriptions

Rank: 54 out of 890

298 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 298 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

16% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 13,245 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 443 419 1 2
WARFARIN SODIUM 367 356 2 24
FUROSEMIDE 361 345 3 7
GABAPENTIN 356 324 4 12
NAMENDA 352 337 5 36
SIMVASTATIN 349 311 6 5
TRAMADOL HCL 331 304 7 16
AMLODIPINE BESYLATE 292 230 8 1
LISINOPRIL 274 244 9 4
DONEPEZIL HCL 264 249 10 30
POTASSIUM CHLORIDE 261 214 11 11
OMEPRAZOLE 236 204 12 8
POLYETHYLENE GLYCOL 3350 213 193 13 67
EXELON 201 191 14 113
AZITHROMYCIN 179 155 15 37
QUETIAPINE FUMARATE 177 159 16 73
HYDROCHLOROTHIAZIDE 176 169 17 9
NEXIUM 175 146 18 14
HYDROCODONE-ACETAMINOPHEN 161 135 S3 19 3
METOPROLOL TARTRATE 160 123 20 15
METOPROLOL SUCCINATE 159 156 21 17
CLOPIDOGREL 151 146 22 28
PRAVASTATIN SODIUM 136 116 23 10
CYMBALTA 130 116 24 45
MEGESTROL ACETATE 128 109 R 25 92
TAMSULOSIN HCL 126 115 26 32
MELOXICAM 125 119 27 18
LANTUS 122 106 28 50
ROPINIROLE HCL 121 103 29 93
KLOR-CON M10 120 101 30 165
SERTRALINE HCL 117 98 31 26
TRAZODONE HCL 115 104 32 40
RANITIDINE HCL 112 99 33 49
KLOR-CON M20 111 104 34 72
DOXAZOSIN MESYLATE 104 85 35 70
CARBIDOPA-LEVODOPA 103 100 36 136
NYSTATIN 102 83 37 173
NITROFURANTOIN MONO-MACRO 101 95 38 181
PANTOPRAZOLE SODIUM 100 99 39 34
PLAVIX 97 92 40 42
ALBUTEROL SULFATE 96 88 41 162
IPRATROPIUM-ALBUTEROL 96 93 41 193
FLUOXETINE HCL 95 93 43 63
DIOVAN 93 89 44 33
CITALOPRAM HBR 90 86 45 20
TRIAMTERENE-HCTZ 90 70 45 61
CARVEDILOL 89 82 47 22
METOCLOPRAMIDE HCL 89 75 47 125
ADVAIR DISKUS 88 86 49 52
COLCRYS 88 85 49 150
AMOX TR-POTASSIUM CLAVULANATE 86 74 51 132
ZETIA 85 63 52 81
PROMETHAZINE HCL 85 61 R 52 104
ALENDRONATE SODIUM 84 72 54 38
FLUTICASONE PROPIONATE 83 81 55 39
CEFTRIAXONE 82 73 56 239
ISOSORBIDE MONONITRATE ER 81 79 57 60
AMIODARONE HCL 80 67 58 206
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 65 59 76
CIPROFLOXACIN HCL 76 71 60 58
METFORMIN HCL 75 32 61 6
DIVALPROEX SODIUM 75 66 61 126
ATENOLOL 73 71 63 23
DIGOXIN 69 69 64 65
FAMOTIDINE 68 68 65 90
ABILIFY 67 63 66 172
AMOXICILLIN 67 63 66 94
ATORVASTATIN CALCIUM 67 67 66 13
PREDNISONE 63 63 69 47
DETROL LA 62 47 70 164
LEVETIRACETAM 61 35 71 137
FLUCONAZOLE 61 58 71 155
MIRTAZAPINE 61 61 71 82
JANTOVEN 60 60 74 169
COMBIVENT 59 56 75 144
RIVASTIGMINE 59 56 75 314
CEPHALEXIN 58 55 77 119
LOSARTAN POTASSIUM 57 44 78 29
RISPERIDONE 57 55 78 78
HYDROXYZINE PAMOATE 57 37 R 78 205
ALLOPURINOL 56 42 81 31
OLANZAPINE 55 26 82 145
RAMIPRIL 55 31 82 80
ESCITALOPRAM OXALATE 54 38 84 51
LIDODERM 54 54 84 227
LIDOCAINE HCL 51 44 86 301
NOVOLIN R 50 37 87 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.